11/30/2022 | CLHY | Market Commentary: Horizon Pharma up on possible buyout; Cubic slides with downgrades; Sebia finalizes terms
|
12/17/2018 | BKCVHY | Moody's lowers Horizon view to stable
|
10/17/2018 | CLHY | Market Commentary: Welbilt, BroadStreet, CPA, Consilio, Park Place, Horizon break; United Natural reworked
|
10/9/2018 | CLHY | Market Commentary: Forming Machining frees up, Dealogic tweaks deal; Paradigm, CPM, Numotion, more set talk
|
10/5/2018 | CLHY | Market Commentary: United Rentals, RevSpring, Fogo de Chao, NFP, GoodRx, J.D. Power, NEP Group, NES break
|
10/17/2017 | CLHY | Market Commentary: Horizon Pharma breaks; Red Ventures, Resolute Investment, Xplornet tweak loan deals
|
5/9/2017 | BKHY | Moody’s: Horizon Pharma view to negative
|
3/23/2017 | CLHY | Market Commentary: Dole Food, BWAY, Horizon Pharma, Citco Funding break; Hargray, Las Vegas Sands update
|
3/22/2017 | CLHY | Market Commentary: Altice, Highline, SFR break; Horizon Pharma, BWAY update; Hargray, RGIS move deadlines
|
3/22/2017 | BKHY | Moody’s rates Horizon Pharma loan Ba2
|
3/14/2017 | CLHY | Market Commentary: Valeant, Arctic Glacier, Camping World, Navico free to trade; Horizon Pharma terms surface
|
3/13/2017 | CLHY | Market Commentary: Contura, Aveanna, Resolute break; Cyxtera, GEO, Cole-Parmer, Kenan, Camping World revised
|
10/20/2016 | CLHY | Market Commentary: Warner, Horizon, Husky, Forterra, Kronos break; Serta, Suddenlink, SCA, Pro Mach revised
|
10/19/2016 | CLHY | Market Commentary: K&N Engineering, CommScope break; Tweddle Group, Horizon Pharma deal changes surface
|
10/13/2016 | BKHY | Moody’s drops Horizon Pharma debt, rates new debt
|
10/13/2016 | BKCVHY | S&P rates Horizon loan BB-, notes B-
|
12/3/2015 | BKBWCVHYLW | Horizon Pharma has 4.6x leverage, could go to 6x for right opportunity
|
4/29/2015 | CLHY | Market Commentary: Horizon Pharma breaks; Avaya updated; Script Relief, Air Canada, Sensata, Veresen launch
|
4/24/2015 | HY | Market Commentary: Three-part ZF Friedrichshafen, Horizon Pharma cap $11.5 billion week, new bonds better
|
4/24/2015 | HY | New Issue: Horizon Pharma prices upsized $475 million eight-year notes at par to yield 6 5/8%
|
4/23/2015 | HY | Market Commentary: Downsized DJO, Trinseo deals, Virgin Media add-on price; Peabody pops; funds lose $162 million
|
4/23/2015 | HY | Horizon Pharma talks upsized $475 million eight-year notes in 6¾% area; pricing Friday
|
4/21/2015 | HY | Market Commentary: Upsized Halcon, Lennar drive-by deals price, move up; existing Halcon paper off on new deal
|
4/21/2015 | BKCVHY | S&P: Horizon Pharma loan BB-, notes B-, convertibles CCC+
|
4/20/2015 | HY | Market Commentary: Levi Strauss drives by to open week, new bonds busy, higher; European issuers step up
|
4/20/2015 | HY | Market Commentary: Levi Strauss drives by to open week, new bonds busy, higher; European issuers step up
|
4/20/2015 | BKHY | Moody’s rates Horizon Pharma loan Ba2, notes B2
|
4/20/2015 | HY | Horizon Pharma starts roadshow for $300 million eight-year notes backing Hyperion acquisition
|
3/19/2014 | BKHY | Horizon Pharma lines up $250 million five-year bridge loan for buyout
|
8/1/2012 | CVHYPF | Horizon Pharma files $175 million shelf for stock, debt, preferreds
|